We’re thrilled to announce that, in recognition of our commitment to quality care delivery, Affect has received accreditation from CARF International. Individuals seeking treatment, health insurance payers, governmental agencies, and the public at-large recognize CARF accreditation as a demonstration of accountability and conformance to standards that promote excellence in treatment of Substance Use Disorders. We…
News
Media mentions and company announcements.
CARF Survey
A survey team from CARF International* will be visiting Affect on 10/10/22 to 10/11/22 We invited the surveyors to evaluate how well we meet international standards for quality. The survey will tell us what we are doing well and ways we might improve. As a result of this survey, we may earn accreditation. As part…
Affect Therapeutics Aims to Curb Stimulant Addiction: Treatment Magazine
Affect Therapeutics Aims to Curb Stimulant Addiction: Treatment Magazine Jason Langendorf writes in Treatment Magazine about Affect’s all-digital treatment program and its roots in contingency management and compulsion loops to activate the brain’s rewards systems. Affect Therapeutics is an integrated recovery program accessed through a proprietary smartphone app, allowing clients to visit counselors and doctors…
Rewarding recovery: how California will pay addicts to give up drugs – Financial Times
Patti Waldmeir writes in the Financial Times about California’s new program for contingency management to address the stimulant addiction crisis, and talked to Affect’s CEO, Kristin Muhlner, about our digital recovery app. Affect Therapeutics is a digital treatment app for methamphetamine, crack and cocaine addiction that uses micropayments — as well as more traditional forms…
This Startup Just Raised $6 Million For An App That Helps Treat Addiction – Forbes
Jair Hilburn writes in Forbes about Affect’s successful close of a funding round to bring its stimulant addiction treatment smartphone app to market. Read more below: Affect Therapeutics, a company working to treat stimulant use disorder through mobile technology, announced Tuesday that it has raised $6 million in a seed investment round. Investors in the…
SUD Stakeholders’ Call to Payers: Contingency Management Key to Treating Stimulant Use Disorder – Behavioral Health Business
In this article for Behavioral Health Business, Bailey Bryant goes deep into issues with insurance companies and behavioral health providers around contingency management, which is shown to be the most effective method in treating stimulant use disorders – and is central in Affect’s approach. Affect’s CEO, Kristin Muhlner, speaks to how getting payer support is…
Affect fights drug addiction with video game design theory in a smartphone app – Cheddar Innovates
Affect’s CEO, Kristin Muhlner chats with ‘Cheddar Innovates’ about how Affect is leveraging the approaches that make games and smartphone apps so engaging to treat methamphetamine and cocaine addictions in a revolutionary way. Transcript: Megan Pratz: Welcome back to Cheddar Innovates, brought to you by CuriosityStream. Our next guest is on a mission to change…
Spotlight on Affect from Rethink Behavioral Health Innovation
Rethink Behavioral Health featured Affect in its Spotlight for new and interesting startups. CEO Kristin Muhlner shared how Affect is changing the way the world treats stimulant use disorders through our digital app for methamphetamine and cocaine addictions. Read more below: Solome: What does Affect Therapeutics do? Kristin: Affect Therapeutics uses mobile technology to revolutionize recovery…
Affect raises a seed round to grow its stimulant abuse recovery service – TechCrunch
Alex Wilhelm at TechCrunch took note when we secured our seed round funding to begin building our app to treat meth and cocaine addiction. Alex, who is in recovery himself from alcohol use disorder, bluntly put it: “The only good amount of meth usage is precisely and exactly zero meth usage. So what Affect is…
Affect combines cash rewards and therapy in an app to fight meth addiction – Forbes
Anne Field interviewed Affect CEO Kristin Muhlner for Forbes in April 2021 about our approach to digital methamphetamine and cocaine addiction treatment. Applying game design theory and incentives to activate the brain’s reward system instead of substance abuse is shown to be more successful in reducing stimulant use. Affect’s app is a gateway to an…